GGrantIndex
Sort

82,697 grants matching vaccine development

Pediatric ACTG Coordinating and Operations Center

$13,829,521
Social And Scientific Systems, Inc. · U01 · FY2004 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: VACCINE MANUFACTURING AND TOXICOLOGY CORE

$13,778,209
Matthew Johnson · Duke University · N01 · FY2019 · AI

HVTN Laboratory Program

$13,724,431
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · U01 · FY2010 · AI

Production of a Broadly Neutralizing HIV Antibodies

$13,723,802
Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2023 · AI

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: UNIVERSAL INFLUENZA RESEARCH

$13,681,100
Florian Krammer · Icahn School Of Medicine At Mount Sinai · N01 · FY2021 · AI

BAA-NIH-NIAID-NCRR-DMID-03-036

$13,656,935
Tulane University Of Louisiana · UC6 · FY2003 · AI

Adol. Medicine Trials Network for HIV/AIDS Interventions

$13,625,773
James J Korelitz · Westat, Inc. · U01 · FY2006 · HD

HIV Vaccine Research and Development

$13,623,109
National Institute Of Allergy And Infectious Diseases · Y01 · FY2015 · AI

BIOD YT

$13,600,000
David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA

Pediatric ACTG Coordinating and Operations Center

$13,579,521
Social And Scientific Systems, Inc. · U01 · FY2005 · AI

National Emerging Infectious Diseases Laboratories Operations

$13,568,475
Ronald B Corley · Boston University Medical Campus · UC7 · FY2014 · AI

High-Dimensional Immune Monitoring of NCI-Supported Immunotherapy Trials

$13,559,983
Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U24 · FY2017 · CA

IMPAACT Leadership Group

$13,535,130
Sharon A Nachman · Johns Hopkins University · UM1 · FY2025 · AI

Advanced Development of Multivalent Filovirus Vaccines

$13,496,364
Janessen Vaccines And Prevention, Bv · N01 · FY2008 · AI

NEW HORIZONS IN THE PREVENTION AND TREATMENT OF FOOD ALLERGY

$13,493,334
Robert A Wood · Johns Hopkins University · UM2 · FY2023 · AI

Modeling Immunity: responses to Bacilus anthracis and anthrax vaccination

$13,475,144
Thomas B Kepler · Duke University · N01 · FY2010 · AI

Development/production of universal influenza vaccines

$13,453,832
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2013 · AI

Development/production of universal influenza vaccines

$13,453,832
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2012 · AI

NCI-Frederick Support and Technical Services

$13,436,235
Craig Reynolds · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Pediatric ACTG Coordinating and Operations Center

$13,434,001
Social And Scientific Systems, Inc. · U01 · FY2003 · AI

Pediatric ACTG Coordinating and Operations Center

$13,432,535
Social And Scientific Systems, Inc. · U01 · FY2002 · AI

ARRA: Process Development and Manufacture of Universal Influenza Vaccine

$13,400,000
Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2010 · AI

Vanderbilt Vaccine and Treatment Evaluation Unit

$13,319,092
Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2022 · AI

HVTN Laboratory Program

$13,310,092
Margaret Juliana McElrath · Fred Hutchinson Cancer Research Center · UM1 · FY2012 · AI

SDMC: HIV Vaccine Trials Network

$13,241,799
Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2015 · AI